GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kaleido Biosciences KLDO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Kaleido Biosciences

Our reporting

We have not reported on Kaleido Biosciences yet.

Next results

3 Mar 2027

Due on 3 Mar 2027. Analysts expect earnings of -0.58 a share on revenue of $91,667.

Past results

Reported against what analysts expected

1 Apr 20221 Nov 202111 Aug 20214 May 20213 Mar 20212 Nov 2020
Earnings per share-0.47-0.54-0.56-0.58-0.56-0.65
Forecast-0.58-0.54-0.57-0.59-0.40-0.63
Revenue$492,000$104,000$211,000$297,000$243,000$482,000
Forecast$1.1m$170,000$110,000$302,033$11.3m$709,477

Key events

  1. 28 Feb 2019Listed

Kaleido Biosciences in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.